Language | Title | Revision | Published | Download PDF | Change history | Printed copy |
---|
Error! A problem has occurred while submitting your data.
The BIOTRONIK Vascular Intervention Business, with the exception of IMDS products, has been acquired by Teleflex, Inc. with effect as of end of day June 30, 2025. These products are no longer part of the BIOTRONIK Group’s portfolio and are now operated and supplied by Teleflex.
For questions or further information relating to former BIOTRONIK Vascular Intervention products, please use the contact form as usual. Any contact requests will be forwarded to the vascular intervention team at Teleflex.
Contact
Contact
California Proposition 65
Note:
This product can expose you to chemicals including ethylene oxide,
which is known to cause cancer and birth defects or other
reproductive harm.
For more information, go to: www.P65Warnings.ca.gov.